InnoCan Pharma Corporation
|
|||
| Mailing Address: | 1015, 926 - 5 Avenue SW Calgary, AB T2P 0N7 |
Head Office Address: | 1015, 926 - 5 Avenue SW Calgary, AB T2P 0N7 |
| Contact Name: | Iris Bincovich | Principal Regulator: | Alberta |
| Business e-mail address: | irisb@innocanpharma.com | Short Form Prospectus Issuer: | Yes |
| Telephone Number: | 972 543012842 | Reporting Jurisdictions: | All provinces and territories of Canada |
| Fax Number: | Stock Exchange: | Canada - CSE | |
| Date of Formation: | May 31 2018 | Stock Symbol: | INNO |
| Jurisdiction Where Formed: | Canada | Auditor: | Ziv Haft CPA (Israel) |
| Industry Classification: | consumer products - biotechnology/pharmaceuticals | General Partner: | |
| CUSIP Number: | 45783P | Transfer Agent: | Odyssey Trust Company |
| Financial Year-End: | Dec 31 | Size of Issuer (Assets): | $5,000,001 to $25,000,000 |
|
